Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Misonix launches faster SonicOne ultrasonic debridement procedure

Misonix, an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and other surgical specialties, released a newly-developed, faster SonicOne O.R. ultrasonic wound debridement procedure.

The procedure is enabled by a new single-use disposable debridement probe with increased ultrasonic amplitude that allows surgeons using the SonicOne device to potentially reduce the operating room time necessary to complete a procedure by up to 50 percent.

Dr. Peter Blume, Assistant Clinical Professor of Orthopedics and Rehabilitation in the Department of Orthopedics, Section of Podiatric Surgery at the Yale University School of Medicine in New Haven, CT, considers the launch of the new SonicOne procedure as an important advancement in the technology.

"The addition of the new faster Ultrasound Assisted Debridement procedure to the SonicOne O.R. system will allow me to utilize the already proven advantages in wound care to larger, more complex wound surfaces. This creates an opportunity to treat a larger segment of the patient population, who had not previously been eligible for the benefits of this approach."

"The benefits of ultrasonic debridement have been well received by the wound community," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix.

The SonicOne O.R. System is an innovative ultrasonic surgical debridement system that allows surgeons to address the challenges chronic wounds present to them, the patient and the health-care system. SonicOne O.R. establishes a new standard in surgical wound bed preparation, an essential first step in the wound healing process.

The new SonicOne procedure will be sold and distributed through the Misonix sales team and the Company’s distributor network in the United States.

Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix’s therapeutic ultrasonic platform is the basis for several innovative medical technologies.

Addressing a combined market estimated to be in excess of $1.5 billion annually; Misonix’s proprietary ultrasonic medical devices are used in spine surgery, neurosurgery, orthopedic surgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical and medical applications.